February 19, 2019 Delving into the Role of Public Private Partnerships in Shaping the Landscape to Enable Precision Medicine for Neurodegeneration | 7th World CNS Summit, Boston, MA
February 8, 2019 Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders
April 24, 2019-April 25, 2019 Tenth Annual Patient-Reported Outcome Consortium Workshop WHAT: Tenth Annual Patient-Reported Outcome Consortium Workshop WHEN: April 24-25, 2019 WHERE: Sheraton Silver Sprin
Critical Path Institute Celebrates Expanded Operations with Opening of European Headquarters C-Path in the EU will work to accelerate the development of new therapies through innovative methodologies for endorsement
Flinn Foundation Awards Critical Path Institute and TGen North a New Grant to Develop and Pilot a System to Respond to Antimicrobial Resistance TUCSON, Ariz., January 8, 2019 — Critical Path Institute (C-Path) and Flagstaff, Arizona-based TGen North — the Pathogen and M
At the IBD Biomarker Summit, Hosted by the Crohn’s & Colitis Foundation, C-Path Shares the Case for formation of an IBD Biomarker Consortium At the IBD Biomarkers Summit, hosted by the Crohn’s & Colitis Foundation on October 17-18, 2018, in Newark, N.J., Critical P
C-Path Board Member Paula Olsiewski Honored as AAAS 2018 Elected Fellow Paula Olsiewski, Ph.D., program director at the Alfred P. Sloan Foundation and Critical Path Institute board member, was named a 2
In Recognition of 10th Anniversary, Raymond Woosley and Janet Woodcock Address CPAD Consortium’s 2018 Annual Meeting and Regulatory Science Workshop At its 10th Annual Meeting and Regulatory Science Workshop, November 13, 2018, in Bethesda, MD, C-Path’s Critical Path for Alzhe